Star Bulk (SBLK) insider Reskos plans 5,000-share sale after prior 10b5-1 trades

Rhea-AI Filing Summary

Nikolaos Reskos filed to sell 5,000 shares of SBLK common stock through Morgan Stanley Smith Barney LLC on NASDAQ, with an approximate aggregate value of $136,950 as of 07/30/2026. These shares relate to an Employee Stock Unit Award dated 09/16/2020. The filing also lists multiple prior Rule 10b5-1 sales of SBLK common stock over the past three months.

Key Figures

Planned shares to be sold: 5,000 shares Estimated value of planned sale: $136,950.00 Grant date of related award: 09/16/2020 +4 more

7 metrics

Planned shares to be sold 5,000 shares Common stock to be sold on NASDAQ as of 07/30/2026

Estimated value of planned sale $136,950.00 Aggregate market value for 5,000 shares in planned sale

Grant date of related award 09/16/2020 Employee Stock Unit Award related to the 5,000 shares

Recent sale 1 20,000 shares for $539,200.00 Common stock sale on 06/11/2026 under 10b5-1

Recent sale 2 5,000 shares for $142,450.00 Common stock sale on 06/01/2026 under 10b5-1

Recent sale 3 30,000 shares for $826,100.00 Common stock sale on 05/21/2026 under 10b5-1

Recent sale 4 33,103 shares for $868,179.15 Common stock sale on 05/18/2026 under 10b5-1

Key Terms

Form 144, 10b5-1, Employee Stock Unit Award, Securities Sold During The Past 3 Months

4 terms

Form 144 regulatory

"144: Securities To Be Sold Common | 09/16/2020 | Employee Stock Unit Award"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

10b5-1 regulatory

"10b5-1 Sales for NIKOLAOS RESKOS 40 Agiou Konstantinou Street"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Employee Stock Unit Award financial

"Common | 09/16/2020 | Employee Stock Unit Award | Issuer"

Securities Sold During The Past 3 Months regulatory

"144: Securities Sold During The Past 3 Months NIKOLAOS RESKOS"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/30/2026 - 05:09 PM Accepted by SEC EDGAR 07/30/2026 - 05:09 PM Learn about SEC filing dates

FAQ

What does the Form 144 filing for SBLK by Nikolaos Reskos cover?

The filing covers a planned sale of 5,000 shares of SBLK common stock, with an approximate aggregate value of $136,950, to be sold on NASDAQ through Morgan Stanley Smith Barney LLC.

When were the SBLK shares in this Form 144 originally awarded to Nikolaos Reskos?

The 5,000 SBLK shares referenced in the Form 144 are tied to an Employee Stock Unit Award dated 09/16/2020, indicating they originated from an equity compensation grant rather than an open-market purchase.

What recent SBLK stock sales has Nikolaos Reskos reported in the past three months?

Recent sales include 20,000 shares for $539,200.00 on 06/11/2026, 5,000 shares for $142,450.00 on 06/01/2026, and 30,000 shares for $826,100.00 on 05/21/2026, all under Rule 10b5-1 plans.

Are the recent SBLK stock sales by Nikolaos Reskos under a Rule 10b5-1 plan?

Yes. The sales listed for 06/11/2026, 06/01/2026, 05/21/2026, 05/20/2026, 05/19/2026, and 05/18/2026 are each described as 10b5-1 Sales, indicating they follow a pre-established trading plan.

Which broker is handling the planned SBLK stock sale in this Form 144?

Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, is listed as handling the proposed sale of 5,000 shares of SBLK common stock on NASDAQ.

What is the total dollar value of the largest recent SBLK sale by Nikolaos Reskos?

The largest individual recent sale disclosed is 33,103 shares of SBLK common stock on 05/18/2026 for approximately $868,179.15, reported as a Rule 10b5-1 sale.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5000	136950.00	111530926	07/30/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/16/2020	Employee Stock Unit Award	Issuer			5000	09/16/2020	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
NIKOLAOS RESKOS 40 Agiou Konstantinou Street Maroussi J3 15124	Common	06/11/2026	20000	539200.00
10b5-1 Sales for NIKOLAOS RESKOS 40 Agiou Konstantinou Street Maroussi J3 15124	Common	06/01/2026	5000	142450.00
10b5-1 Sales for NIKOLAOS RESKOS 40 Agiou Konstantinou Street Maroussi J3 15124	Common	05/21/2026	30000	826100.00
10b5-1 Sales for NIKOLAOS RESKOS 40 Agiou Konstantinou Street Maroussi J3 15124	Common	05/20/2026	9914	263234.55
10b5-1 Sales for NIKOLAOS RESKOS 40 Agiou Konstantinou Street Maroussi J3 15124	Common	05/19/2026	86	2278.14
10b5-1 Sales for NIKOLAOS RESKOS 40 Agiou Konstantinou Street Maroussi J3 15124	Common	05/18/2026	33103	868179.15

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)